Company: HCTI
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026218
Chunk: 51

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 51
---
 estate.

Item 3. Legal Proceedings

From time to time, we may be subject to legal
proceedings and claims in the ordinary course of business. We may in the future receive claims from third parties asserting, among other
things, infringement of their intellectual property rights. Future litigation may be necessary to defend ourselves, our partners and our
customers by determining the scope, enforceability and validity of third-party proprietary rights, or to establish our proprietary rights.
The results of any future litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse
impact on us. To date, we have not been made aware of any actual, pending or threatened litigation against the Company.

Item 4. Mine Safety Disclosures

Not applicable.

33

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder
Matters and Issuer Purchases of Equity Securities.

Market Information

Our common stock is trading on the Nasdaq Capital Market under the
symbol “HCTI.”

Holders

As of March 31, 2025, there were 41 stockholders
of record of our common stock. Because many of our shares of common stock are held by brokers and other institutions on behalf of stockholders,
this number is not representative of the total number of beneficial owners of our stock.

Dividends

We have never declared or paid any cash dividend
on our common stock. We intend to retain any future earnings to finance the operation and expansion of our business and fund our share
repurchase program, and we do not expect to pay cash dividends in the foreseeable future.

Recent Sales of Unregistered Securities

None

Securities Authorized for Issuance under Equity Compensation Plans

The following table provides information as of December 31, 2024, regarding
our common stock that may be issued under the Plan(2)

    Plan category: 
    Number of Securities to 
be issued Upon Exercise of Outstanding Options, Warrants, and Rights (a)  
    Weighted Average Exercise Price of Outstanding Options (b)  
    Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in column (a)) (c) 
  
    Equity compensation plans approved by stockholders (1) 
     276,500  
    $3.7  
     1,023,050 
  
    Total 
     276,500  
    $3.7  
     1